Conference Coverage

VIDEO: Watch for anxiety, other symptoms in cannabis users on anti-cannabinoids


 

AT THE SUMMIT IN NEUROLOGY & PSYCHIATRY

References

WASHINGTON – The physical withdrawal symptoms of cannabis users given anti-cannabinoids resemble those of people withdrawing from opioid use by taking naloxone, according to Dr. Mark S. Gold. In this interview, recorded at the Summit in Neurology & Psychiatry sponsored by the Global Academy for Medical Education, Dr. Gold of the department of psychiatry at Washington University in St. Louis, describes withdrawal from cannabis, including symptoms of anxiety, panic, and confusion. Global Academy and this news organization are owned by the same company.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

ICOO: Massachusetts governor takes on opioid epidemic
MDedge Internal Medicine
Poison center calls for fake pot up 330% in first half of 2015
MDedge Internal Medicine
‘Dabbing’ on the rise: Is this marijuana use dangerous?
MDedge Internal Medicine
ICOO: Quality metrics needed for medical marijuana
MDedge Internal Medicine
ICOO: Opioids blurring criminal activity and malpractice
MDedge Internal Medicine
To sleep, perchance to reprogram behaviors?
MDedge Internal Medicine
Legislation aims to improve treatment of serious mental illness
MDedge Internal Medicine
Morphine synthesis finding paves way for new painkillers
MDedge Internal Medicine
WCD: Smoking tied to worse occupational hand eczema
MDedge Internal Medicine
VIDEO: Beware of dehydration, hyperthermia in drug-taking concert-goers, or ‘ravers’*
MDedge Internal Medicine